George Grandolfi, PhD

Vice President, Drug Product and Formulation

Dr. Grandolfi has more than 25 years' experience in managing the development, production and commercialization of a broad range of drug products. His expertise spans drug substance and drug product development, including formulation/process development, analytical testing, manufacturing, scale-up, technology transfer, stability and packaging. Dr. Grandolfi has overseen the development of many types of dosage forms and was responsible for the CMC sections of numerous regulatory submissions, including four approved New Drug Applications. Previously, Dr. Grandolfi was Vice President, Chemistry, Manufacturing, and Controls for Amarin Pharma. Earlier in his career, he held positions of increasing responsibility at Boehringer Ingelheim, DuPont-Merck, Cephalon, Alkermes and Spherics. Dr. Grandolfi holds a BS in Pharmacy from the University of Rhode Island, an MS in Pharmaceutics from the University of Wisconsin–Madison and a PhD in Pharmaceutics and Pharmaceutical Chemistry from The Ohio State University.